Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review

To review the evidence for the use of open-inhaler (inhaled corticosteroid [ICS] plus long-acting β